tim Search Results


95
R&D Systems kidney injury molecule 1
Kidney Injury Molecule 1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/kidney injury molecule 1/product/R&D Systems
Average 95 stars, based on 1 article reviews
kidney injury molecule 1 - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

94
R&D Systems tim3
(A) A UMAP showing the integration of tumour and benign cells of the TME, and healthy lymph node data from two public studies (PMID35027729, PMID39566559). Cells are coloured according to the data source, and scANVI-predicted cell types are shown in (B), (C) and (D). Images of an ALK+ ALCL case colored by Cell2location-predicted cell type abundances in each Visium spot. (C) Predictions for the locations of malignant cells, <t>TIM3+</t> T cells (T_TIM3+) and cytotoxic T cells (T_CD8+_cytotoxic), (D) Predictions for the locations of dark zone B cells (B_GC_DZ), light zone B cells (B_GC_LZ) and follicular dendritic cells (FDC). (E) A dotplot showing non-negative matrix factorisation (NMF) factors, where each factor is a group of co-localized cell types. In the dotplot, the size and color density represent the loading of each cell type in each factor. (F) Staining of TIM3 and CD30 expression on two representative ALK+ ALCL cases (G) Summary of the % TIM3+ infiltrating T lymphocytes in each of the 9 ALK+ ALCL cases analysed.
Tim3, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tim3/product/R&D Systems
Average 94 stars, based on 1 article reviews
tim3 - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

95
R&D Systems goat anti kim 1 antibody
(A) A UMAP showing the integration of tumour and benign cells of the TME, and healthy lymph node data from two public studies (PMID35027729, PMID39566559). Cells are coloured according to the data source, and scANVI-predicted cell types are shown in (B), (C) and (D). Images of an ALK+ ALCL case colored by Cell2location-predicted cell type abundances in each Visium spot. (C) Predictions for the locations of malignant cells, <t>TIM3+</t> T cells (T_TIM3+) and cytotoxic T cells (T_CD8+_cytotoxic), (D) Predictions for the locations of dark zone B cells (B_GC_DZ), light zone B cells (B_GC_LZ) and follicular dendritic cells (FDC). (E) A dotplot showing non-negative matrix factorisation (NMF) factors, where each factor is a group of co-localized cell types. In the dotplot, the size and color density represent the loading of each cell type in each factor. (F) Staining of TIM3 and CD30 expression on two representative ALK+ ALCL cases (G) Summary of the % TIM3+ infiltrating T lymphocytes in each of the 9 ALK+ ALCL cases analysed.
Goat Anti Kim 1 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti kim 1 antibody/product/R&D Systems
Average 95 stars, based on 1 article reviews
goat anti kim 1 antibody - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

93
R&D Systems elisa kits
(A) A UMAP showing the integration of tumour and benign cells of the TME, and healthy lymph node data from two public studies (PMID35027729, PMID39566559). Cells are coloured according to the data source, and scANVI-predicted cell types are shown in (B), (C) and (D). Images of an ALK+ ALCL case colored by Cell2location-predicted cell type abundances in each Visium spot. (C) Predictions for the locations of malignant cells, <t>TIM3+</t> T cells (T_TIM3+) and cytotoxic T cells (T_CD8+_cytotoxic), (D) Predictions for the locations of dark zone B cells (B_GC_DZ), light zone B cells (B_GC_LZ) and follicular dendritic cells (FDC). (E) A dotplot showing non-negative matrix factorisation (NMF) factors, where each factor is a group of co-localized cell types. In the dotplot, the size and color density represent the loading of each cell type in each factor. (F) Staining of TIM3 and CD30 expression on two representative ALK+ ALCL cases (G) Summary of the % TIM3+ infiltrating T lymphocytes in each of the 9 ALK+ ALCL cases analysed.
Elisa Kits, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kits/product/R&D Systems
Average 93 stars, based on 1 article reviews
elisa kits - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc n a tim3 cell signalling technology 45208 n a
(A) A UMAP showing the integration of tumour and benign cells of the TME, and healthy lymph node data from two public studies (PMID35027729, PMID39566559). Cells are coloured according to the data source, and scANVI-predicted cell types are shown in (B), (C) and (D). Images of an ALK+ ALCL case colored by Cell2location-predicted cell type abundances in each Visium spot. (C) Predictions for the locations of malignant cells, <t>TIM3+</t> T cells (T_TIM3+) and cytotoxic T cells (T_CD8+_cytotoxic), (D) Predictions for the locations of dark zone B cells (B_GC_DZ), light zone B cells (B_GC_LZ) and follicular dendritic cells (FDC). (E) A dotplot showing non-negative matrix factorisation (NMF) factors, where each factor is a group of co-localized cell types. In the dotplot, the size and color density represent the loading of each cell type in each factor. (F) Staining of TIM3 and CD30 expression on two representative ALK+ ALCL cases (G) Summary of the % TIM3+ infiltrating T lymphocytes in each of the 9 ALK+ ALCL cases analysed.
N A Tim3 Cell Signalling Technology 45208 N A, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n a tim3 cell signalling technology 45208 n a/product/Cell Signaling Technology Inc
Average 95 stars, based on 1 article reviews
n a tim3 cell signalling technology 45208 n a - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

93
R&D Systems pd1 pe
(A) A UMAP showing the integration of tumour and benign cells of the TME, and healthy lymph node data from two public studies (PMID35027729, PMID39566559). Cells are coloured according to the data source, and scANVI-predicted cell types are shown in (B), (C) and (D). Images of an ALK+ ALCL case colored by Cell2location-predicted cell type abundances in each Visium spot. (C) Predictions for the locations of malignant cells, <t>TIM3+</t> T cells (T_TIM3+) and cytotoxic T cells (T_CD8+_cytotoxic), (D) Predictions for the locations of dark zone B cells (B_GC_DZ), light zone B cells (B_GC_LZ) and follicular dendritic cells (FDC). (E) A dotplot showing non-negative matrix factorisation (NMF) factors, where each factor is a group of co-localized cell types. In the dotplot, the size and color density represent the loading of each cell type in each factor. (F) Staining of TIM3 and CD30 expression on two representative ALK+ ALCL cases (G) Summary of the % TIM3+ infiltrating T lymphocytes in each of the 9 ALK+ ALCL cases analysed.
Pd1 Pe, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pd1 pe/product/R&D Systems
Average 93 stars, based on 1 article reviews
pd1 pe - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

92
R&D Systems rhtim 3 fc af647
(A) A UMAP showing the integration of tumour and benign cells of the TME, and healthy lymph node data from two public studies (PMID35027729, PMID39566559). Cells are coloured according to the data source, and scANVI-predicted cell types are shown in (B), (C) and (D). Images of an ALK+ ALCL case colored by Cell2location-predicted cell type abundances in each Visium spot. (C) Predictions for the locations of malignant cells, <t>TIM3+</t> T cells (T_TIM3+) and cytotoxic T cells (T_CD8+_cytotoxic), (D) Predictions for the locations of dark zone B cells (B_GC_DZ), light zone B cells (B_GC_LZ) and follicular dendritic cells (FDC). (E) A dotplot showing non-negative matrix factorisation (NMF) factors, where each factor is a group of co-localized cell types. In the dotplot, the size and color density represent the loading of each cell type in each factor. (F) Staining of TIM3 and CD30 expression on two representative ALK+ ALCL cases (G) Summary of the % TIM3+ infiltrating T lymphocytes in each of the 9 ALK+ ALCL cases analysed.
Rhtim 3 Fc Af647, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rhtim 3 fc af647/product/R&D Systems
Average 92 stars, based on 1 article reviews
rhtim 3 fc af647 - by Bioz Stars, 2026-06
92/100 stars
  Buy from Supplier

95
Bio X Cell k anti mouse tim 3 mab
(A) A UMAP showing the integration of tumour and benign cells of the TME, and healthy lymph node data from two public studies (PMID35027729, PMID39566559). Cells are coloured according to the data source, and scANVI-predicted cell types are shown in (B), (C) and (D). Images of an ALK+ ALCL case colored by Cell2location-predicted cell type abundances in each Visium spot. (C) Predictions for the locations of malignant cells, <t>TIM3+</t> T cells (T_TIM3+) and cytotoxic T cells (T_CD8+_cytotoxic), (D) Predictions for the locations of dark zone B cells (B_GC_DZ), light zone B cells (B_GC_LZ) and follicular dendritic cells (FDC). (E) A dotplot showing non-negative matrix factorisation (NMF) factors, where each factor is a group of co-localized cell types. In the dotplot, the size and color density represent the loading of each cell type in each factor. (F) Staining of TIM3 and CD30 expression on two representative ALK+ ALCL cases (G) Summary of the % TIM3+ infiltrating T lymphocytes in each of the 9 ALK+ ALCL cases analysed.
K Anti Mouse Tim 3 Mab, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/k anti mouse tim 3 mab/product/Bio X Cell
Average 95 stars, based on 1 article reviews
k anti mouse tim 3 mab - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

93
Bio X Cell anti mouse tim1
C57BL/6 transgenic mice expressing the hen egg lysozyme–specific, MD4 BCR fail to develop tolerance to BALB/c islets when treated with anti-CD45RB and <t>anti-TIM1,</t> compared to WT C57BL/6, which reliably develop tolerance post antibody treatment. *P < .05. BCR, B cell receptor; WT, wild type
Anti Mouse Tim1, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti mouse tim1/product/Bio X Cell
Average 93 stars, based on 1 article reviews
anti mouse tim1 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

93
Bio X Cell pd 1
C57BL/6 transgenic mice expressing the hen egg lysozyme–specific, MD4 BCR fail to develop tolerance to BALB/c islets when treated with anti-CD45RB and <t>anti-TIM1,</t> compared to WT C57BL/6, which reliably develop tolerance post antibody treatment. *P < .05. BCR, B cell receptor; WT, wild type
Pd 1, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pd 1/product/Bio X Cell
Average 93 stars, based on 1 article reviews
pd 1 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

99
R&D Systems mouse tim 1 kim
C57BL/6 transgenic mice expressing the hen egg lysozyme–specific, MD4 BCR fail to develop tolerance to BALB/c islets when treated with anti-CD45RB and <t>anti-TIM1,</t> compared to WT C57BL/6, which reliably develop tolerance post antibody treatment. *P < .05. BCR, B cell receptor; WT, wild type
Mouse Tim 1 Kim, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse tim 1 kim/product/R&D Systems
Average 99 stars, based on 1 article reviews
mouse tim 1 kim - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

Image Search Results


(A) A UMAP showing the integration of tumour and benign cells of the TME, and healthy lymph node data from two public studies (PMID35027729, PMID39566559). Cells are coloured according to the data source, and scANVI-predicted cell types are shown in (B), (C) and (D). Images of an ALK+ ALCL case colored by Cell2location-predicted cell type abundances in each Visium spot. (C) Predictions for the locations of malignant cells, TIM3+ T cells (T_TIM3+) and cytotoxic T cells (T_CD8+_cytotoxic), (D) Predictions for the locations of dark zone B cells (B_GC_DZ), light zone B cells (B_GC_LZ) and follicular dendritic cells (FDC). (E) A dotplot showing non-negative matrix factorisation (NMF) factors, where each factor is a group of co-localized cell types. In the dotplot, the size and color density represent the loading of each cell type in each factor. (F) Staining of TIM3 and CD30 expression on two representative ALK+ ALCL cases (G) Summary of the % TIM3+ infiltrating T lymphocytes in each of the 9 ALK+ ALCL cases analysed.

Journal: bioRxiv

Article Title: Single-Cell Profiling Reveals Developmental Trajectories and identifies SYK and TIM3 as Targets in some T Cell Lymphomas

doi: 10.64898/2026.03.27.714741

Figure Lengend Snippet: (A) A UMAP showing the integration of tumour and benign cells of the TME, and healthy lymph node data from two public studies (PMID35027729, PMID39566559). Cells are coloured according to the data source, and scANVI-predicted cell types are shown in (B), (C) and (D). Images of an ALK+ ALCL case colored by Cell2location-predicted cell type abundances in each Visium spot. (C) Predictions for the locations of malignant cells, TIM3+ T cells (T_TIM3+) and cytotoxic T cells (T_CD8+_cytotoxic), (D) Predictions for the locations of dark zone B cells (B_GC_DZ), light zone B cells (B_GC_LZ) and follicular dendritic cells (FDC). (E) A dotplot showing non-negative matrix factorisation (NMF) factors, where each factor is a group of co-localized cell types. In the dotplot, the size and color density represent the loading of each cell type in each factor. (F) Staining of TIM3 and CD30 expression on two representative ALK+ ALCL cases (G) Summary of the % TIM3+ infiltrating T lymphocytes in each of the 9 ALK+ ALCL cases analysed.

Article Snippet: Following heat-mediated antigen retrieval, consecutive sections were stained for TIM3 (MAB23652, R&D Systems) and CD30 (M0751, Agilent Dako) both at a 1:50 dilution.

Techniques: Staining, Expressing

C57BL/6 transgenic mice expressing the hen egg lysozyme–specific, MD4 BCR fail to develop tolerance to BALB/c islets when treated with anti-CD45RB and anti-TIM1, compared to WT C57BL/6, which reliably develop tolerance post antibody treatment. *P < .05. BCR, B cell receptor; WT, wild type

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Article Title: Regulatory B cells require antigen recognition for effective allograft tolerance induction

doi: 10.1111/ajt.15739

Figure Lengend Snippet: C57BL/6 transgenic mice expressing the hen egg lysozyme–specific, MD4 BCR fail to develop tolerance to BALB/c islets when treated with anti-CD45RB and anti-TIM1, compared to WT C57BL/6, which reliably develop tolerance post antibody treatment. *P < .05. BCR, B cell receptor; WT, wild type

Article Snippet: Islet recipient mice also received 500 μg anti-mouse TIM1 (clone RMT1–10, BioXCell, West Lebanon, NH) ip on day 0, and 300 μg on days 1 and 5 following transplantation.

Techniques: Transgenic Assay, Expressing

Phenotype of B cells from naive and long-term graft survivor (LTS) OBI mice. A, Surface staining of B cells from naive and LTS OBI mice show similar levels of TIM1 and CD5 and higher levels of CD40. B, Tolerant OBI B cells show an increased proportion of LAP+ (a marker for TGF-β production) B cells upon stimulation with LPS, PMA, and ionomycin. C, Tolerant OBI B cells, however, do not show upregulation of IL-10 under the same stimulation protocol. Data are representative of 3 experiments. ns, nonsignificant. *P < .05. LPS, lipopolysaccharide; MFI, median flourescence intensity; OBI, ovalbumin (OVA)-specific BCR mice; PMA, phorbol myristate acetate; TGF, transforming growth factor

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Article Title: Regulatory B cells require antigen recognition for effective allograft tolerance induction

doi: 10.1111/ajt.15739

Figure Lengend Snippet: Phenotype of B cells from naive and long-term graft survivor (LTS) OBI mice. A, Surface staining of B cells from naive and LTS OBI mice show similar levels of TIM1 and CD5 and higher levels of CD40. B, Tolerant OBI B cells show an increased proportion of LAP+ (a marker for TGF-β production) B cells upon stimulation with LPS, PMA, and ionomycin. C, Tolerant OBI B cells, however, do not show upregulation of IL-10 under the same stimulation protocol. Data are representative of 3 experiments. ns, nonsignificant. *P < .05. LPS, lipopolysaccharide; MFI, median flourescence intensity; OBI, ovalbumin (OVA)-specific BCR mice; PMA, phorbol myristate acetate; TGF, transforming growth factor

Article Snippet: Islet recipient mice also received 500 μg anti-mouse TIM1 (clone RMT1–10, BioXCell, West Lebanon, NH) ip on day 0, and 300 μg on days 1 and 5 following transplantation.

Techniques: Staining, Marker